Pulmonology, Respiratory Health | News, Articles, Research



Fluvoxamine Evaluated in Patients With Mild COVID-19

The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.

Novavax COVID-19 Vaccine Candidate Fast Tracked

NVX-CoV2373 is engineered from the genetic sequence of severe acute respiratory syndrome coronavirus 2 using the recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.

Next post in News